The Antibiotics In Miscarriage Surgery (AIMS) trial
- Conditions
- Infection, miscarriage, sepsis, antibiotic prophylaxisPregnancy and Childbirth
- Registration Number
- ISRCTN97143849
- Lead Sponsor
- niversity of Birmingham (UK)
- Brief Summary
1. 2018 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/29685179 2. 2019 results in https://www.ncbi.nlm.nih.gov/pubmed/30865795 (added 14/03/2019) 3. 2018 systematic review in https://www.ncbi.nlm.nih.gov/pubmed/29739349 4. 2019 cost-effectiveness analysis in: https://www.ncbi.nlm.nih.gov/pubmed/31402008 (added 14/08/2019)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 3412
1. Women with a spontaneous miscarriage (under 22 weeks gestation)
2. Women undergoing surgical evacuation of the uterus (by manual vacuum aspiration, suction curettage or sharp curettage)
3. Willing and able to give informed consent
1. Induced abortion of pregnancy
2. Septic miscarriage or evidence of infection
3. Allergy to either of the antibiotics
4. Current antibiotic use, or antibiotic use in the 7 days preceding surgical evacuation
5. Current febrile illness (temperature < 38oC)
7. Other contraindication to doxycycline or metronidazole use
8. Patient with condition requiring immediate care e.g. severe haemorrhage
9. Age less than 16 years
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method